Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 32 citing articles:

Schistosomiasis vaccine development: update on human clinical trials
Adebayo J. Molehin
Journal of Biomedical Science (2020) Vol. 27, Iss. 1
Open Access | Times Cited: 122
Vaccines for Human Schistosomiasis: Recent Progress, New Developments and Future Prospects
Adebayo J. Molehin, Donald P. McManus, Hong You
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2255-2255
Open Access | Times Cited: 54
Schistosoma mansoni vaccine candidates identified by unbiased phage display screening in self-cured rhesus macaques
Daisy W Santos, Ana Carolina Tahira, João V. M. Malvezzi, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Schistosomiasis and hookworm infection in humans: Disease burden, pathobiology and anthelmintic vaccines
A Anisuzzaman, Naotoshi Tsuji
Parasitology International (2020) Vol. 75, pp. 102051-102051
Closed Access | Times Cited: 64
Sm‐p80‐based schistosomiasis vaccine: double‐blind preclinical trial in baboons demonstrates comprehensive prophylactic and parasite transmission‐blocking efficacy
Weidong Zhang, Adebayo J. Molehin, Juan U. Rojo, et al.
Annals of the New York Academy of Sciences (2018) Vol. 1425, Iss. 1, pp. 38-51
Open Access | Times Cited: 52
Drug discovery technologies: Caenorhabditis elegans as a model for anthelmintic therapeutics
Daniel Sepúlveda‐Crespo, Rosa M. Reguera, F.A. Rojo-Vázquez, et al.
Medicinal Research Reviews (2020) Vol. 40, Iss. 5, pp. 1715-1753
Closed Access | Times Cited: 40
Human Schistosomiasis Vaccines as Next Generation Control Tools
Peter J. Hotez, María Elena Bottazzi
Tropical Medicine and Infectious Disease (2023) Vol. 8, Iss. 3, pp. 170-170
Open Access | Times Cited: 11
Therapeutic challenges of schistosomiasis: mechanisms of action and current limitations
Abdelaali Balahbib, Nasreddine El Omari, Hajar Lghazi, et al.
Journal of Parasitic Diseases (2025)
Closed Access
A functional enzymatic assay as potential readout for a clinical trial of a schistosomiasis vaccine
Desalegn W. Kifle, Mumtaz Yaseen Balkhi, Yasuko Ono, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
Sm‐p80‐based vaccine trial in baboons: efficacy when mimicking natural conditions of chronic disease, praziquantel therapy, immunization, and Schistosoma mansoni re‐encounter
Arif Jamal Siddiqui, Adebayo J. Molehin, Weidong Zhang, et al.
Annals of the New York Academy of Sciences (2018) Vol. 1425, Iss. 1, pp. 19-37
Closed Access | Times Cited: 31
A comprehensive and critical overview of schistosomiasis vaccine candidates
Aya Al-Naseri, Samar Al-Absi, Rashika El Ridi, et al.
Journal of Parasitic Diseases (2021) Vol. 45, Iss. 2, pp. 557-580
Open Access | Times Cited: 23
Schistosoma egg-induced liver pathology resolution by Sm-p80-based schistosomiasis vaccine in baboons
Loc Le, Adebayo J. Molehin, Stewart Nash, et al.
Pathology (2018) Vol. 50, Iss. 4, pp. 442-449
Open Access | Times Cited: 25
Fifteen Years of Sm-p80-Based Vaccine Trials in Nonhuman Primates: Antibodies From Vaccinated Baboons Confer Protection in vivo and in vitro From Schistosoma mansoni and Identification of Putative Correlative Markers of Protection
Weidong Zhang, Loc Le, Gul Ahmad, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 23
Natural Intra- and Interclade Human Hybrid Schistosomes in Africa with Considerations on Prevention through Vaccination
Ursula Panzner, Jérôme Boissier
Microorganisms (2021) Vol. 9, Iss. 7, pp. 1465-1465
Open Access | Times Cited: 20
Schistosoma Mansoni Antigen Sm-p80: Prophylactic Efficacy using TLR4 Agonist Vaccine Adjuvant Glucopyranosyl Lipid A-Alum in Murine and Non-Human Primate Models
Weidong Zhang, Gul Ahmad, Adebayo J. Molehin, et al.
Journal of Investigative Medicine (2018) Vol. 66, Iss. 8, pp. 1124-1132
Open Access | Times Cited: 21
A low dose adenovirus vectored vaccine expressing Schistosoma mansoni Cathepsin B protects from intestinal schistosomiasis in mice
Dilhan J. Perera, Adam S. Hassan, Sunny S. Liu, et al.
EBioMedicine (2022) Vol. 80, pp. 104036-104036
Open Access | Times Cited: 12
Molecular characterization and functional analysis of the Schistosoma mekongi Ca2+-dependent cysteine protease (calpain)
Salisa Chaimon, Yanin Limpanont, Onrapak Reamtong, et al.
Parasites & Vectors (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 18
Recent Advances and Methodological Considerations on Vaccine Candidates for Human Schistosomiasis
Ursula Panzner, Jean‐Louis Excler, Jérôme H. Kim, et al.
Frontiers in Tropical Diseases (2021) Vol. 2
Open Access | Times Cited: 15
Transmission-Blocking Vaccines against Schistosomiasis Japonica
Chika P. Zumuk, Malcolm K. Jones, Séverine Navarro, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1707-1707
Open Access | Times Cited: 2
Calpain inhibitor suppresses both extracellular vesicle-mediated secretion of miRNAs and egg production from paired adults of Schistosoma japonicum
T. Kumagai, Rieko Shimogawara, Koichiro Ichimura, et al.
Parasitology International (2022) Vol. 87, pp. 102540-102540
Closed Access | Times Cited: 8
A Comparative Analysis of the Protein Cargo of Extracellular Vesicles from Helminth Parasites
María Eugenia Ancarola, Lucas Maldonado, Lucía Celia Abril García, et al.
Life (2023) Vol. 13, Iss. 12, pp. 2286-2286
Open Access | Times Cited: 4
Process Development of Sj-p80: A Low-Cost Transmission-Blocking Veterinary Vaccine for Asiatic Schistosomiasis
Adebayo J. Molehin, Sean A. Gray, Cheri Turner, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 10
Molecular Characterization and Functional Analysis of a Schistosoma mansoni Serine Protease Inhibitor, Smserpin-p46
Christine N. Lee, B. Hall, Leah Sanford, et al.
Microorganisms (2024) Vol. 12, Iss. 6, pp. 1164-1164
Open Access | Times Cited: 1
Therapeutic and vaccinomic potential of moonlighting proteins for the discovery and design of drugs and vaccines against schistosomiasis
Kagiso Motlhatlhedi, Naledi Beatrice Pilusa, Thoko Ndaba, et al.
American Journal of Translational Research (2024) Vol. 16, Iss. 9, pp. 4279-4300
Closed Access | Times Cited: 1
Schistosoma antigens: A future clinical magic bullet for autoimmune diseases?
Mphatso Chaponda, Ho Yin Pekkle Lam
Parasite (2024) Vol. 31, pp. 68-68
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top